Dialing-Up The Immune System
to develop effective and safe treatments for cancer
Candela is a unit of light
At Candel Therapeutics, our team is developing oncolytic viral immunotherapies that light up and empower the immune system to fight cancer
We calibrate our approaches
Our viral-based approaches allow us to calibrate our immunotherapy treatments to each cancer that we target
The patient is always our focal point
Our viral immunotherapies are being designed to have favorable benefit-to-risk profiles, in an effort to ensure patients have efficacious and safe treatments across disease stages
